• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

抗生素使用模式与艰难梭菌感染导致的住院风险

Patterns of antibiotic use and risk of hospital admission because of Clostridium difficile infection.

作者信息

Dial Sandra, Kezouh Abbas, Dascal Andre, Barkun Alan, Suissa Samy

机构信息

Department of Medicine, Sir Mortimer B. Davis-Jewish General Hospital, McGill University, Montréal, Que.

出版信息

CMAJ. 2008 Oct 7;179(8):767-72. doi: 10.1503/cmaj.071812.

DOI:10.1503/cmaj.071812
PMID:18838451
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2553880/
Abstract

BACKGROUND

Previous observations have indicated that infection with Clostridium difficile occurs almost exclusively after exposure to antibiotics, but more recent observations have suggested that prior antibiotic exposure may be less frequent among cases of community-acquired disease.

METHODS

We used 2 linked health databases to perform a matched, nested case-control study of elderly patients admitted to hospital with community-acquired C. difficile infection. For each of 836 cases among people 65 years of age or older, we selected 10 controls. We determined the proportion of cases that occurred without prior antibiotic exposure and estimated the risk related to exposure to different antibiotics and the duration of increased risk.

RESULTS

Of the 836 cases, 442 (52.9%) had no exposure to antibiotics in the 45-day period before the index date, and 382 (45.7%) had no exposure in the 90-day period before the index date. Antibiotic exposure was associated with a rate ratio (RR) of 10.6 (95% confidence interval [CI] 8.9-12.8). Clindamycin (RR 31.8, 95% CI 17.6-57.6), cephalosporins (RR 14.9, 95% CI 10.9-20.3) and gatifloxacin (RR 16.7, 95% CI 8.3-33.6) were associated with the highest risk. The RR for C. difficile infection associated with antibiotic exposure declined from 15.4 (95% CI 12.2-19.3) by about 20 days after exposure to 3.2 (95% CI 2.0-5.0) after 45 days. Use of a proton pump inhibitor was associated with increased risk (RR 1.6, 95% CI 1.3-2.0), as were concurrent diagnoses of inflammatory bowel disease (RR 4.1, 95% CI 2.6-6.6), irritable bowel syndrome (RR 3.4, 95% CI 2.3-5.0) and renal failure (RR 1.7, 95% CI 1.2-2.2).

INTERPRETATION

Community-acquired C. difficile infection occurred in a substantial proportion of individuals with no recent exposure to antibiotics. Among patients who had been exposed to antibiotics, the risk declined markedly by 45 days after discontinuation of use.

摘要

背景

既往观察表明,艰难梭菌感染几乎仅在接触抗生素后发生,但最近的观察提示,社区获得性疾病病例中既往抗生素接触可能不那么常见。

方法

我们使用两个相关的健康数据库,对因社区获得性艰难梭菌感染入院的老年患者进行匹配的巢式病例对照研究。对于65岁及以上人群中的836例病例,我们各选取10名对照。我们确定了无既往抗生素接触而发生的病例比例,并估计了与接触不同抗生素相关的风险以及风险增加的持续时间。

结果

在836例病例中,442例(52.9%)在索引日期前45天内未接触抗生素,382例(45.7%)在索引日期前90天内未接触抗生素。抗生素接触与率比(RR)为10.6(95%置信区间[CI]8.9 - 12.8)相关。克林霉素(RR 31.8,95% CI 17.6 - 57.6)、头孢菌素(RR 14.9,95% CI 10.9 - 20.3)和加替沙星(RR 16.7,95% CI 8.3 - 33.6)与最高风险相关。与抗生素接触相关的艰难梭菌感染RR在接触后约20天从15.4(95% CI 12.2 - 19.3)降至45天后的3.2(95% CI 2.0 - 5.0)。使用质子泵抑制剂与风险增加相关(RR 1.6,95% CI 1.3 - 2.0),同时诊断为炎症性肠病(RR 4.1,95% CI 2.6 - 6.6)、肠易激综合征(RR 3.4,95% CI 2.3 - 5.0)和肾衰竭(RR 1.7,95% CI 1.2 - 2.2)时也是如此。

解读

相当一部分近期未接触抗生素的个体发生了社区获得性艰难梭菌感染。在接触过抗生素的患者中,停药后45天时风险显著下降。

相似文献

1
Patterns of antibiotic use and risk of hospital admission because of Clostridium difficile infection.抗生素使用模式与艰难梭菌感染导致的住院风险
CMAJ. 2008 Oct 7;179(8):767-72. doi: 10.1503/cmaj.071812.
2
Community-associated Clostridium difficile infection among older people in Tayside, Scotland, is associated with antibiotic exposure and care home residence: cohort study with nested case-control.苏格兰泰赛德地区老年人社区获得性艰难梭菌感染与抗生素暴露及养老院居住有关:嵌套病例对照队列研究
J Antimicrob Chemother. 2013 Dec;68(12):2927-33. doi: 10.1093/jac/dkt257. Epub 2013 Jul 3.
3
Risk of Clostridium difficile diarrhea among hospital inpatients prescribed proton pump inhibitors: cohort and case-control studies.住院患者中开具质子泵抑制剂处方后发生艰难梭菌腹泻的风险:队列研究和病例对照研究
CMAJ. 2004 Jul 6;171(1):33-8. doi: 10.1503/cmaj.1040876.
4
Antibiotic exposure and risk of community-associated Clostridium difficile infection: A self-controlled case series analysis.抗生素暴露与社区相关性艰难梭菌感染的风险:一项自身对照病例系列分析。
Am J Infect Control. 2019 Jan;47(1):9-12. doi: 10.1016/j.ajic.2018.06.016. Epub 2018 Aug 29.
5
Effect of a national 4C antibiotic stewardship intervention on the clinical and molecular epidemiology of Clostridium difficile infections in a region of Scotland: a non-linear time-series analysis.国家 4C 抗生素管理干预对苏格兰某地区艰难梭菌感染的临床和分子流行病学的影响:非线性时间序列分析。
Lancet Infect Dis. 2017 Feb;17(2):194-206. doi: 10.1016/S1473-3099(16)30397-8. Epub 2016 Nov 4.
6
infection: Is there a change in the underlying factors? Inflammatory bowel disease and .感染:潜在因素是否有变化?炎症性肠病和。
Saudi J Gastroenterol. 2019 Nov-Dec;25(6):384-389. doi: 10.4103/sjg.SJG_44_19.
7
Hospital ward antibiotic prescribing and the risks of Clostridium difficile infection.医院病房抗生素处方与艰难梭菌感染的风险。
JAMA Intern Med. 2015 Apr;175(4):626-33. doi: 10.1001/jamainternmed.2014.8273.
8
Cumulative and temporal associations between antimicrobial prescribing and community-associated Clostridium difficile infection: population-based case-control study using administrative data.抗菌药物处方与社区获得性艰难梭菌感染之间的累积和时间关联:基于人群的病例对照研究,使用行政数据
J Antimicrob Chemother. 2017 Apr 1;72(4):1193-1201. doi: 10.1093/jac/dkw528.
9
Proton pump inhibitor use and risk of community-acquired Clostridium difficile-associated disease defined by prescription for oral vancomycin therapy.质子泵抑制剂的使用与因口服万古霉素治疗处方所定义的社区获得性艰难梭菌相关疾病的风险
CMAJ. 2006 Sep 26;175(7):745-8. doi: 10.1503/cmaj.060284.
10
Clostridium difficile infections in a Canadian tertiary care hospital before and during a regional epidemic associated with the BI/NAP1/027 strain.加拿大一家三级护理医院在与BI/NAP1/027菌株相关的地区性疫情之前及期间的艰难梭菌感染情况。
Antimicrob Agents Chemother. 2008 Sep;52(9):3180-7. doi: 10.1128/AAC.00146-08. Epub 2008 Jun 23.

引用本文的文献

1
Appropriateness of antimicrobial therapy in medical wards of a tertiary care referral hospital and its effect on antibiotic consumption and in-hospital mortality.三级转诊医院内科病房抗菌治疗的合理性及其对抗生素使用和住院死亡率的影响。
Indian J Pharmacol. 2025 Jul 1;57(4):242-246. doi: 10.4103/ijp.ijp_131_23. Epub 2025 Jul 21.
2
Comparison of Different Antibiotics and the Risk for Community-Associated Infection: A Case-Control Study.不同抗生素与社区获得性感染风险的比较:一项病例对照研究
Open Forum Infect Dis. 2023 Aug 5;10(8):ofad413. doi: 10.1093/ofid/ofad413. eCollection 2023 Aug.
3
Host Immunity and Immunization Strategies for Clostridioides difficile Infection.艰难梭菌感染的宿主免疫与免疫策略。
Clin Microbiol Rev. 2023 Jun 21;36(2):e0015722. doi: 10.1128/cmr.00157-22. Epub 2023 May 10.
4
Proton pump Inhibitors and Risk of Enteric Infection in Inflammatory Bowel Disease: A Self-controlled Case Series.质子泵抑制剂与炎症性肠病肠道感染的风险:一项自身对照病例系列研究。
Inflamm Bowel Dis. 2024 Jan 5;30(1):38-44. doi: 10.1093/ibd/izad035.
5
Reduction strategies for inpatient oral third-generation cephalosporins at a cancer center: An interrupted time-series analysis.癌症中心住院患者口服第三代头孢菌素的减少策略:一项中断时间序列分析。
PLoS One. 2023 Feb 9;18(2):e0281518. doi: 10.1371/journal.pone.0281518. eCollection 2023.
6
Characterization of the Fecal Microbiome in Dogs Receiving Medical Management for Congenital Portosystemic Shunts.接受先天性门体分流症药物治疗的犬类粪便微生物群特征分析。
Front Vet Sci. 2022 Jul 28;9:897760. doi: 10.3389/fvets.2022.897760. eCollection 2022.
7
Association of Adverse Events With Antibiotic Treatment for Urinary Tract Infection.抗生素治疗尿路感染不良事件的关联。
Clin Infect Dis. 2022 Apr 28;74(8):1408-1418. doi: 10.1093/cid/ciab637.
8
Variants at the MHC Region Associate With Susceptibility to Infection: A Genome-Wide Association Study Using Comprehensive Electronic Health Records.MHC 区域的变异与感染易感性相关:一项基于全面电子健康记录的全基因组关联研究。
Front Immunol. 2021 Mar 25;12:638913. doi: 10.3389/fimmu.2021.638913. eCollection 2021.
9
Proton-Pump Inhibitor Use and the Risk of Community-Associated Clostridium difficile Infection.质子泵抑制剂的使用与社区获得性艰难梭菌感染的风险。
Clin Infect Dis. 2021 Jun 15;72(12):e1084-e1089. doi: 10.1093/cid/ciaa1857.
10
Evaluating the appropriateness of carbapenem and piperacillin-tazobactam prescribing in a tertiary care hospital in Saudi Arabia.评估沙特阿拉伯一家三级护理医院中碳青霉烯类和哌拉西林-他唑巴坦处方的合理性。
Saudi Pharm J. 2020 Nov;28(11):1492-1498. doi: 10.1016/j.jsps.2020.09.015. Epub 2020 Sep 25.

本文引用的文献

1
A case-control study of community-associated Clostridium difficile infection.一项关于社区相关性艰难梭菌感染的病例对照研究。
J Antimicrob Chemother. 2008 Aug;62(2):388-96. doi: 10.1093/jac/dkn163. Epub 2008 Apr 22.
2
Historical perspectives on studies of Clostridium difficile and C. difficile infection.艰难梭菌及艰难梭菌感染研究的历史视角
Clin Infect Dis. 2008 Jan 15;46 Suppl 1:S4-11. doi: 10.1086/521865.
3
Fluoroquinolone use and risk factors for Clostridium difficile-associated disease within a Veterans Administration health care system.退伍军人管理局医疗系统中氟喹诺酮类药物的使用与艰难梭菌相关疾病的风险因素
Clin Infect Dis. 2007 Nov 1;45(9):1141-51. doi: 10.1086/522187. Epub 2007 Sep 26.
4
The challenges posed by reemerging Clostridium difficile infection.艰难梭菌再发感染带来的挑战。
Clin Infect Dis. 2007 Jul 15;45(2):222-7. doi: 10.1086/518874. Epub 2007 Jun 4.
5
ICD-9 codes and surveillance for Clostridium difficile-associated disease.用于艰难梭菌相关疾病的国际疾病分类第九版编码及监测
Emerg Infect Dis. 2006 Oct;12(10):1576-9. doi: 10.3201/eid1210.060016.
6
Accuracy of ICD-9 coding for Clostridium difficile infections: a retrospective cohort.国际疾病分类第九版(ICD-9)对艰难梭菌感染编码的准确性:一项回顾性队列研究
Epidemiol Infect. 2007 Aug;135(6):1010-3. doi: 10.1017/S0950268806007655. Epub 2006 Dec 7.
7
Narrative review: the new epidemic of Clostridium difficile-associated enteric disease.叙述性综述:艰难梭菌相关性肠道疾病的新流行情况
Ann Intern Med. 2006 Nov 21;145(10):758-64. doi: 10.7326/0003-4819-145-10-200611210-00008.
8
Proton pump inhibitors and hospitalization for Clostridium difficile-associated disease: a population-based study.质子泵抑制剂与艰难梭菌相关性疾病住院治疗:一项基于人群的研究。
Clin Infect Dis. 2006 Nov 15;43(10):1272-6. doi: 10.1086/508453. Epub 2006 Oct 13.
9
Proton pump inhibitor use and risk of community-acquired Clostridium difficile-associated disease defined by prescription for oral vancomycin therapy.质子泵抑制剂的使用与因口服万古霉素治疗处方所定义的社区获得性艰难梭菌相关疾病的风险
CMAJ. 2006 Sep 26;175(7):745-8. doi: 10.1503/cmaj.060284.
10
Gastric acid-suppressive agents and risk of Clostridium difficile-associated disease.胃酸抑制剂与艰难梭菌相关性疾病的风险
JAMA. 2006 Jun 14;295(22):2599; author reply 2600-1. doi: 10.1001/jama.295.22.2599-a.